Absorption of epi-doxorubicin after intravesical administration of patients with in situ transitional cell carcinoma of the bladder

K. Mross; P. Maessen; W. J F Van Der Vijgh; J. F. Bogdanowicz; K. H. Kurth; H. M. Pinedo

doi:10.1016/0277-5379(87)90310-5

Absorption of epi-doxorubicin after intravesical administration of patients with in situ transitional cell carcinoma of the bladder

K. Mross, P. Maessen, W. J F Van Der Vijgh, J. F. Bogdanowicz, K. H. Kurth, H. M. Pinedo

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Abstract

Nine patients with in situ bladder cancer (TIS) were treated by intravesical instillation of epi-doxorubicin (epi-DOX). The amount of anthracycline in 1 ml plasma was in the nanogram range. 78.9 ± 12.0% and 84.2 ± 10.6% of the administered dose (30 and 50 mg, respectively) could be recovered.

Original language	English (US)
Pages (from-to)	505-508
Number of pages	4
Journal	European Journal of Cancer and Clinical Oncology
Volume	23
Issue number	5
DOIs	https://doi.org/10.1016/0277-5379(87)90310-5
State	Published - 1987
Externally published	Yes

ASJC Scopus subject areas

Oncology

Access to Document

10.1016/0277-5379(87)90310-5

Cite this

@article{e1588e8834cd455580418b59e7d63f03,

title = "Absorption of epi-doxorubicin after intravesical administration of patients with in situ transitional cell carcinoma of the bladder",

abstract = "Nine patients with in situ bladder cancer (TIS) were treated by intravesical instillation of epi-doxorubicin (epi-DOX). The amount of anthracycline in 1 ml plasma was in the nanogram range. 78.9 ± 12.0% and 84.2 ± 10.6% of the administered dose (30 and 50 mg, respectively) could be recovered.",

author = "K. Mross and P. Maessen and {Van Der Vijgh}, {W. J F} and Bogdanowicz, {J. F.} and Kurth, {K. H.} and Pinedo, {H. M.}",

year = "1987",

doi = "10.1016/0277-5379(87)90310-5",

language = "English (US)",

volume = "23",

pages = "505--508",

journal = "European Journal of Cancer and Clinical Oncology",

issn = "0277-5379",

publisher = "Pergamon Press",

number = "5",

}

TY - JOUR

T1 - Absorption of epi-doxorubicin after intravesical administration of patients with in situ transitional cell carcinoma of the bladder

AU - Mross, K.

AU - Maessen, P.

AU - Van Der Vijgh, W. J F

AU - Bogdanowicz, J. F.

AU - Kurth, K. H.

AU - Pinedo, H. M.

PY - 1987

Y1 - 1987

N2 - Nine patients with in situ bladder cancer (TIS) were treated by intravesical instillation of epi-doxorubicin (epi-DOX). The amount of anthracycline in 1 ml plasma was in the nanogram range. 78.9 ± 12.0% and 84.2 ± 10.6% of the administered dose (30 and 50 mg, respectively) could be recovered.

AB - Nine patients with in situ bladder cancer (TIS) were treated by intravesical instillation of epi-doxorubicin (epi-DOX). The amount of anthracycline in 1 ml plasma was in the nanogram range. 78.9 ± 12.0% and 84.2 ± 10.6% of the administered dose (30 and 50 mg, respectively) could be recovered.

UR - http://www.scopus.com/inward/record.url?scp=0023092644&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023092644&partnerID=8YFLogxK

U2 - 10.1016/0277-5379(87)90310-5

DO - 10.1016/0277-5379(87)90310-5

M3 - Article

C2 - 3477456

AN - SCOPUS:0023092644

SN - 0277-5379

VL - 23

SP - 505

EP - 508

JO - European Journal of Cancer and Clinical Oncology

JF - European Journal of Cancer and Clinical Oncology

IS - 5

ER -

Absorption of epi-doxorubicin after intravesical administration of patients with in situ transitional cell carcinoma of the bladder

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this